首页|期刊导航|中国比较医学杂志|黑皮质素受体激动剂改善Shank3基因缺陷孤独症模型大鼠行为的机制研究

黑皮质素受体激动剂改善Shank3基因缺陷孤独症模型大鼠行为的机制研究OA

Possible mechanisms underlying improvement of autism-like behaviors by melanocortin receptor agonists in Shank3-deficient rats

中文摘要英文摘要

目的 探讨黑皮质素受体激动剂(MT-II)改善SH3 和多个锚蛋白重复结构域 3(Shank3)基因缺陷孤独症模型鼠社交缺陷的作用机制.方法 利用Shank3 干扰慢病毒和空载慢病毒注射至仔鼠右侧脑室构建Shank3 模型鼠和空载鼠各 18 只,Shank3 组随机分为Shank3+Sal(Sh3-Sal)组 9 只和Shank3+MT-II(Sh3-MT-II)组 9 只,空载组随机分为空载+Sal(V-Sal)组 9 只和空载+MT-II(V-MT-II)组 9 只.V-MT-II组和Sh3-MT-II组于第 28 天腹腔注射 3.3 mL/kg MT-II,V-Sal组和Sh3-Sal组腹腔注射3.3 mL/kg 0.9%氯化钠溶液,通过旷场实验、理毛实验、三箱社交实验及Morris水迷宫实验评估其行为学改变;采用逆转录聚合酶链式反应(RT-PCR)和蛋白免疫印迹(Western blot)检测下丘脑催产素(OXT)、催产素受体(OXTR)及黑皮质素受体 4(MC4R)的mRNA与蛋白表达水平.结果 行为学结果显示,三箱社交实验中与陌生鼠 1 相比,Sh3-Sal组未表现出社交差异(P>0.05),而MT-II干预后,Sh3-MT-II组与陌生鼠 2 的社交时间显著增加,差异有统计学意义(P<0.01).Morris水迷宫实验中与V-Sal组相比,Sh3-Sal组表现出显著的学习记忆障碍(P<0.05),而MT-II干预后,Sh3-MT-II组学习记忆能力明显提高,差异有统计学意义(P<0.01).旷场实验和理毛实验结果显示,与V-Sal组相比,Sh3-Sal组周边停留时间及理毛时间均显著增加,差异有统计学意义(P<0.01);MT-II干预后,旷场中心停留时间及理毛行为与Sh3-Sal组无显著差异(P>0.05).RT-PCR检测显示,与Sh3-Sal组相比,Sh3-MT-II组OXT、OXTR和MC4R mRNA表达水平明显升高,差异有统计学意义(P<0.05);Western blot法检测显示,与Sh3-Sal组相比,Sh3-MT-II组大鼠下丘脑OXT蛋白表达水平明显升高(P<0.05),与V-Sal组相比,Sh3-Sal组和Sh3-MT-II组大鼠下丘脑SHANK3 蛋白表达水平明显降低(P<0.05,P<0.01),而OXTR及MC4R蛋白表达水平无显著差异(P>0.05).结论 黑皮质素受体激动剂MT-II可能通过激活下丘脑OXT系统改善Shank3 缺陷孤独症模型鼠的社交障碍,提示靶向OXT/MC4R通路或为孤独症社交缺陷的潜在干预策略.

Objective To explore the mechanism by which melanotan-II(MT-II)improves social deficits in a Shank3 gene-deficient autism model.Methods Rats were divided into control and Shank3-deficient model groups(n=18 per group)treated by microinjection of empty or Shank3-interfering lentivirus,respectively,into the right lateral ventricle of neonatal rats.Shank3-deficient rats were further divided randomly into two groups:Shank3+saline(Sh3-Sal)and Shank3+MT-II(Sh3-MT-II)groups(n=9 per group).Similarly,control rats were divided into control+saline(V-Sal)and control+MT-II(V-MT-II)groups(n=9 per group).On day 28,rats in the V-MT-II and Sh3-MT-II groups received intraperitoneal(i.p.)injections of MT-II(3.3 mg/kg),while rats in the V-Sal and Sh3-Sal groups received i.p.saline(3.3 mL/kg).Behavioral changes were assessed using the open-field test,grooming behavior analysis,three-chamber social test,and the Morris water maze test.mRNA and protein expression levels of hypothalamic oxytocin(OXT),OXT receptor(OXTR),and melanocortin receptor 4(MC4R)were detected by reverse transcription-polymerase chain reaction and Western blot,respectively.Results In the three-chamber social test,Sh3-Sal group rats showed no significant social preference compared with the time spent with stranger rat 1(P>0.05).In contrast,after MT-II intervention,Sh3-MT-II group rats spent significantly longer with stranger rat 2(P<0.01).In the Morris water maze test,rats in the Sh3-Sal group exhibited significant learning and memory impairments compared with the V-Sal group(P<0.05),while MT-II intervention significantly improved the learning and memory performance of the Sh3-MT-II group(P<0.01).The open field and grooming tests revealed that Sh3-Sal group rats spent significantly longer in the peripheral zone of the open field and exhibited increased grooming behavior compared with the V-Sal group(P<0.01).However,MT-II did not significantly alter the center time or self-grooming behavior compared with the Sh3-Sal group(P>0.05).mRNA expression levels of OXT,OXTR,and MC4R were significantly higher in the Sh3-MT-II group than in the Sh3-Sal group(P<0.05,P<0.01).Hypothalamic OXT protein expression was significantly increased in the Sh3-MT-II group compared with the Sh3-Sal group(P<0.05),while hypothalamic SHANK3 protein expression was significantly decreased in both the Sh3-Sal and Sh3-MT-II groups compared with the V-Sal group(P<0.05,P<0.01),and protein expression levels of OXTR and MC4R showed no significant changes(P>0.05).Conclusions The melanocortin receptor agonist MT-II may ameliorate social deficits in Shank3-deficient autistic rats by activating the hypothalamic OXT system.This suggests that targeting the OXT/MC4R pathway could be a potential therapeutic strategy for social deficits in patients with autism spectrum disorder.

陈晓芳;王娟;欧萍;陈思洁;黄龙生

晋江市妇幼保健院,福建 泉州 362200福建医科大学,福州 351022福建省妇幼保健院,福州 350001福建省妇幼保健院,福州 350001晋江市妇幼保健院,福建 泉州 362200||福建省妇幼保健院,福州 350001

医药卫生

孤独症谱系障碍Shank3缺陷黑皮质素受体激动剂行为学催产素

autism spectrum disorderShank3-deficiencymelanocortin receptor agonistbehavioroxytocin

《中国比较医学杂志》 2026 (6)

41-50,10

福建省科技创新联合资金项目(2024Y9578)福建省卫生健康重大科研专项(2024ZD01005).

10.3969/j.issn.1671-7856.2026.06.005

评论